17/07/2026 - Campus Can Ruti, Projects

IGTP launches MOSAIC, a transformative project to advance more preventive, participatory and sustainable community health

The Germans Trias i Pujol Research Institute (IGTP) will launch the MOSAIC project (Models in Community Health and Collaborative Innovation), an institutional initiative aimed at promoting new forms of health research and innovation, firmly rooted in the local area and focused on generating tangible benefits for the population. The project is part of the Government of Catalonia's Regions del Coneixement program and is co-funded by the European Regional Development Fund (ERDF) under the RIS3CAT 2030 strategy.

16/07/2026 - Campus Can Ruti, Projects

ITSready launches as the first project in Catalonia and Spain to integrate digital tools to improve STI prevention, early diagnosis and awareness among young people

Funded by La Marató de 3Cat and jointly led by CEEISCAT-IGTP, FLI, ASPB and CJAS, the project offers three digital tools designed to improve knowledge about STIs and facilitate access to diagnosis for young people aged 16 to 25 across Catalonia: a free self-sampling kits to detect HIV, chlamydia and gonorrhoea from home, an anonymous partner notification tool and a chatbot providing validated information on sexual health.

15/07/2026 - Campus Can Ruti, Research

New algorithm improves gene expression marker identification across diverse biological systems

Researchers from IGTP, UPC, IrsiCaixa and CIBEREHD have developed the Cartesian Distance-Based Gene Expression (CDBGE) approach, a novel algorithm designed to identify the genes that best distinguish between different biological conditions.

13/07/2026 - Campus Can Ruti, Research

A pilot clinical trial led by Germans Trias provides the first clinical proof of concept for ibuprofen as an adjunctive treatment for tuberculosis

The study, published in Nature Communications, evaluates ibuprofen for the first time in patients with tuberculosis as an adjunctive therapy aimed at modulating the host inflammatory response. The results did not show an improvement in the main clinical or microbiological outcomes, but they did reveal biological changes consistent with reduced inflammation, supporting further investigation of this approach in larger, controlled trials.

09/07/2026 - Campus Can Ruti, Projects, Research

BST and IGTP are advancing the use of the particles that cells use to communicate as revolutionary therapies for the future

Researchers from BST, IGTP and Biosfer Teslab have demonstrated the potential of Nuclear Magnetic Resonance to monitor and optimise the manufacture of extracellular vesicles, one of the most promising therapeutic platforms in regenerative medicine. The findings, published in the Journal of Extracellular Vesicles, could help facilitate the development and scale-up of these therapies.

01/07/2026 - Campus Can Ruti, Institutional, Success Stories

19 IGTP researchers, recognised in a scientific impact ranking

A total of 19 women researchers affiliated with the Germans Trias i Pujol Research Institute (IGTP) feature in the April 2026 edition of the Ranking of Spanish Women Researchers and Women Researchers in Spain, reflectig the relevance of the research conducted both at the institute and across the Can Ruti Campus.

18/06/2026 - Campus Can Ruti, Conferences, Innovation, Success Stories

The Innomed Awards support emerging biomedical projects with potential for transfer in health

The 3^rd Innomed Awards brought together professionals from research, healthcare, entrepreneurship and investment, with the presentation of the 15 projects taking part in the new edition of GrowInn and recognition for the seven projects with the greatest potential.

16/06/2026 - Campus Can Ruti, Projects

IGTP coordinates a new European COST Action on neurofibromatosis and schwannomatosis

IGTP will coordinate INTERACT-NF, a new European COST Action that will bring together 68 researchers from 13 countries to advance research on neurofibromatosis and schwannomatosis. The network will foster collaboration between researchers, clinicians and patient organisations to address the main challenges associated with these rare diseases.

15/06/2026 - Campus Can Ruti, Projects, Research

WHO launches an international study on the Andes hantavirus outbreak coordinated by professionals from the Germans Trias Hospital

Roger Paredes (Germans Trias Hospital, IrsiCaixa and the Fight Infections Foundation) coordinates the international NAVIS study, launched by the WHO to advance knowledge of Andes hantavirus. The initiative also includes an advanced virology and immunology study coordinated by IrsiCaixa and IGTP Principal Investigators Julià Blanco and Nuria Izquierdo-Useros.

12/06/2026 - Campus Can Ruti, Outreach, Success Stories

La Marató visits return to the IGTP laboratories to bring science closer to the public

IGTP has concluded a new cycle of visits to its laboratories as a part of La Marató "Visita la Recerca" program. More than fifty people had the opportunity to explore the biomedical research carried out at the institute through talks, workshops, and guided tours of the laboratories and facilities.